Full Text View
Tabular View
Study Results
Related Studies
Safety and Efficacy of AGN 203818 for Pain Associated With Fibromyalgia Syndrome
This study has been terminated.
( This study was terminated early due to company decision. Part B was never conducted. )
Study NCT00445705   Information provided by Allergan

First Received on March 7, 2007.   Last Updated on December 16, 2011   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Fibromyalgia
Additional conditions recognized in this trial
Myofascial Pain Syndromes
More general conditions related to this trial
Muscular Diseases
Musculoskeletal Diseases
Nervous System Diseases
Neuromuscular Diseases
Rheumatic Diseases
Interventions listed in this trial
placebo
AGN 203818
Sponsors listed in this trial
Allergan


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services